Stifel Nicolaus Reaffirms Their Buy Rating on Iron Mountain (IRM)
π Stifel Nicolaus analyst Shlomo Rosenbaum reaffirmed a Buy rating on Iron Mountain (IRM) with a new price target of $140.00.
π The company's stock has received a Strong Buy consensus from Wall Street analysts with an average price target of $136.50.
π° Based on quarterly earnings through March 31, Iron Mountain reported revenue of $1.94 billion and net profit of $143.67 million.
π Revenue for the quarter grew significantly compared to last year's figures, with profits rising from $15.95 million to over $143 million.
π Analyst Rosenbaum has a 49.40% success rate and an average return of 2.9% on recommended stocks within the Financial sector.
β οΈ Corporate insider sentiment is currently negative due to increased selling activity among 68 insiders in the past quarter.
πΈ Director Jennifer Allerton recently sold 7,000 shares totaling $762,160 in March 2026, representing a notable recent exit by leadership.
π’ Truist raised its price target for Iron Mountain to $140 from $130 as part of their latest research update.
π JPMorgan increased its price target on the stock to $138 from a previous level of $121.
πΉ The company adjusted its 2026 AFFO view upward to a range of $5.79-$5.86 from the prior estimate of $5.69-$5.79.
π― Management guidance for Q2 EPS has been set at $1.40, compared to an analyst consensus of 55 cents.
- Stifel Nicolaus reaffirmed their Buy rating on Iron Mountain (IRM) with a price target raised to $140.00.
- The Street consensus indicates a Strong Buy rating with an average price target of $136.50, signaling broad analyst confidence.
- Iron Mountain reported significant growth in quarterly revenue, reaching $1.94 billion compared to $1.59 billion last year.
- Net profit surged from $15.95 million in the prior year to $143.67 million for the quarter ending March 31.
- Management raised their 2026 AFFO view to a range of $5.79-$5.86, up from the previous guidance of $5.69-$5.79.
- Iron Mountain provided strong Q2 EPS guidance of $1.40, which is substantially higher than the consensus estimate of 55 cents.
- Corporate insider sentiment is negative on the stock, with 68 insiders having recently increased their selling activity of IRM shares compared to earlier in the year.
- In March 2026, Director Jennifer Allerton sold 7,000 shares for $762,160.00, adding to recent insider selling pressure.
- The price target estimates vary significantly among analysts: while Stifel sets it at $140, Truist had raised their target from $121 to $138, and JPMorgan has its own target of $138, indicating a lack of uniform bullish consensus despite the 'Strong Buy' rating label.
- The article notes that the Street suggests a Strong Buy consensus with a $136.50 average price target, but this may not fully reflect underlying risks given the specific analyst divergences mentioned.